Aptose Biosciences Filed For Resale Of Up To 1.26M Common Shares By Selling Shareholder
Portfolio Pulse from Charles Gross
Aptose Biosciences has filed for the resale of up to 1.26 million common shares by a selling shareholder.
June 20, 2023 | 10:03 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aptose Biosciences filed for the resale of up to 1.26 million common shares, which may lead to short-term selling pressure.
The filing for resale of 1.26 million common shares by a selling shareholder may lead to an increase in the supply of APTO shares in the market. This could result in short-term selling pressure and a potential decrease in the stock price.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100